<DOC>
	<DOCNO>NCT01336270</DOCNO>
	<brief_summary>Melanoma tumor tissue ( particular regressive area ) present lymphocytic infiltrate anti-tumoral specificity . The aim study analyse different stage disease , tumor sample characterise cellular infiltrate situ ( particular T lymphocyte , NK cell macrophage ) , role inhibitor receptor situ immunosuppression , potential modulation medical treatment dacarbazine .</brief_summary>
	<brief_title>Characterisation T Lymphocytes , NK Cells Macrophages Melanoma Patients</brief_title>
	<detailed_description>The study divide 4 part : Part 1 : study cellular infiltrate ( lymphocyte ) perform large primary melanoma cutaneous metastasis ( fresh sample ) Part 2 : NK cell study metastatic regional lymph node ( fresh sample ) blood sample Part 3 : retrospective study macrophage sentinel lymph node correspond primary melanoma Part 4 : study cellular modulation chemotherapy ( DTIC cisplatin inhibitor B-raf ) ( ) make two cutaneous metastasis patient ( one take treatment ( process ) one take evaluation 2 3 cycle treatment ( process ) )</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<criteria>Patients confirm melanomapatients inform aim study , modality Patients sign consent form ou non opposition form sign patient relative According study part : Part 1 : patient melanoma large 10mm cutaneous metastasis Part 2 : stage IV melanoma patient shall undergo regional lymph node dissection Part 3 : retrospective study patient underwent sentinel node procedure Part 4 : Patients achieve inoperable melanoma stage ( stadium ) III IV must receive treatment ( process ) chemotherapy ( dacarbazine cisplatin inhibitor Braf ) carrier least two cutaneous metastasis Refusal take part study ( patient relative ) Contraindications know xylocaine ( group 1,2 , 4 ) No affiliated social security system ( group 1 , 2 , 4 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Melanoma</keyword>
	<keyword>NK cell</keyword>
	<keyword>T lymphocyte</keyword>
	<keyword>macrophage</keyword>
</DOC>